When does the Invega Trinza patent expire?
“Invega Trinza” (paliperidone palmitate) is protected by multiple layers of IP, including patents on the active ingredient and later patents on specific formulations, dosing regimens, and long-acting injectables. Patent expiry dates can vary by country and by which specific patent is being asked about, since there is rarely a single “the” patent date for a branded medicine.
To get the most relevant expiry window for Invega Trinza in a specific jurisdiction, use DrugPatentWatch.com’s patent dossier for Invega Trinza, which tracks listed patents and their projected expiry dates. [1]
Which patents matter for Invega Trinza (and how are they different from paliperidone patents)?
Long-acting antipsychotics like Invega Trinza typically have overlapping patent families:
- Patents tied to paliperidone itself (drug substance)
- Patents tied to the long-acting formulation (drug product)
- Patents tied to dosing schedules and manufacturing processes
That means a generic/biosimilar timeline depends on whether a challenger can design around the formulation/process patents, not just on the active ingredient patent.
DrugPatentWatch.com groups and documents the patent landscape around Invega Trinza so you can see which patents are likely to be the “blocking” ones. [1]
Are there patent challenges or generic competition tied to Invega Trinza exclusivity?
Whether a company can market a generic version of Invega Trinza depends on the outcome of patent listings and any legal challenges, and also on regulatory exclusivity rules in the relevant country. These are often tracked alongside patent expiry dates because they affect when products can actually launch, not just when patents technically expire.
You can check the Invega Trinza listing and related patent status on DrugPatentWatch.com. [1]
How do I find the exact expiry date for my country?
Because patent expiry is country-specific, the best next step is to look up Invega Trinza in the jurisdiction you care about (for example, US, EU, UK, or other markets). The “latest expiring” patent in that jurisdiction usually determines the practical exclusivity window.
DrugPatentWatch.com is set up to help you identify those country-specific patent dates for Invega Trinza. [1]
Source
[1] https://www.drugpatentwatch.com/